Jun 18, 2026
16 MIN READ

Managing Constipation on Wegovy: Effective Strategies for Relief

Constipation affects up to 25% of semaglutide users during the first weeks of treatment. PlexusDx explains practical dietary and lifestyle adjustments that reduce discomfort while you achieve your weight loss goals.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 18, 2026
16 MIN READ

managing constipation on wegovy: effective strategies for relief — PlexusDx GLP-1 education

Last reviewed: June 18, 2026

Last updated: June 18, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide slows stomach emptying to reduce hunger, which can lead to constipation in roughly one-quarter of patients during early treatment phases. This side effect is temporary and manageable with targeted interventions. Understanding how your GLP-1 therapy affects your digestive system helps you stay compliant and comfortable throughout your weight loss journey.

Why Semaglutide Causes Constipation and Slow Digestion

Semaglutide works by mimicking glucagon-like peptide-1, a hormone that signals fullness to your brain and slows the rate at which food moves from your stomach into your intestines. This delayed gastric emptying is the mechanism that suppresses appetite, but it also reduces the natural muscle contractions in your colon that push stool forward. When your digestive tract moves more slowly overall, water has more time to be reabsorbed, making stools firmer and harder to pass.

Most patients experience constipation within the first two to four weeks of starting semaglutide, particularly during dose increases. The effect typically lessens as your body adapts to the medication, though some individuals continue to experience mild constipation throughout treatment. Recognizing this as a predictable, dose-dependent side effect—not a sign of medication failure—helps you approach management proactively rather than stopping a therapy that is working for weight loss.

Hydration and Fiber: The Foundation of Digestive Comfort

Increasing water intake is the first and most effective step for semaglutide users experiencing constipation. Aim for at least 8 to 10 glasses of water daily, spreading intake evenly throughout the day rather than consuming large amounts at once. Since semaglutide reduces appetite, you may forget to drink adequate fluids; setting phone reminders or carrying a marked water bottle helps ensure consistent hydration. Proper hydration softens stool and supports colon function without relying on medications.

Soluble fiber—found in oats, beans, apples, and psyllium—absorbs water and creates bulk that stimulates bowel movements. Introduce fiber gradually over one to two weeks to avoid bloating and gas, which can occur when fiber intake increases too quickly. Insoluble fiber from whole grains, vegetables, and nuts also promotes regularity. A combination of both types, supported by adequate water, addresses constipation at the physiological level and complements your semaglutide therapy without interfering with its weight loss benefits.

Movement and Lifestyle Modifications That Restore Bowel Regularity

Physical activity stimulates intestinal contractions and accelerates food movement through your digestive tract. Walking for 20 to 30 minutes after meals, practicing yoga, or engaging in strength training three to four times per week can significantly reduce constipation severity in semaglutide users. Exercise also supports weight loss independently, multiplying the benefits of your GLP-1 therapy. Even light movement—such as leisurely walking—produces measurable improvements in bowel function.

Establishing a consistent bathroom routine signals your colon to prepare for elimination. Schedule time for a bowel movement at the same hour each day, ideally 30 minutes after meals when the gastrocolic reflex naturally stimulates colon activity. Avoid delaying the urge to have a bowel movement, as this can worsen constipation over time. Reducing stress through meditation or deep breathing also supports digestive function, since the gut-brain axis means anxiety can tighten colon muscles and slow transit.

Over-the-Counter and Prescription Options for Persistent Constipation

If dietary and lifestyle changes do not resolve constipation within one to two weeks, osmotic laxatives such as polyethylene glycol (MiraLAX) or magnesium citrate can help by drawing water into the colon and softening stool. These are non-habit-forming and gentle enough for long-term use. Stool softeners like docusate work differently by reducing the surface tension of stool, making passage easier without increasing bowel frequency. Avoid stimulant laxatives (such as senna or bisacodyl) as daily treatments, since they can lead to dependence and reduced colon responsiveness over time.

For constipation that persists despite aggressive hydration, fiber, and osmotic laxatives, prescription medications such as lubiprostone or linaclotide increase fluid secretion in the small intestine and promote bowel movements without the dependence risk of stimulant laxatives. Discuss any new medications with your PlexusDx provider to ensure compatibility with your semaglutide dose and overall treatment plan. In rare cases where constipation is severe or accompanied by abdominal pain, bloating, or vomiting, seek immediate medical evaluation to rule out bowel obstruction or other complications.

When to Contact Your PlexusDx Provider About Constipation

PlexusDx recommends reaching out to your care team if constipation lasts longer than five to seven days despite home remedies, if you experience severe abdominal pain or cramping, or if you notice blood in your stool. Your provider may adjust your semaglutide dose timing, recommend specific over-the-counter products, or modify your overall treatment plan to improve tolerability. Open communication about side effects ensures your therapy remains both effective and sustainable.

Some patients benefit from reducing their semaglutide dose temporarily while intensifying hydration and fiber intake, allowing the gastrointestinal system to adapt more gradually. Your PlexusDx provider can help you balance constipation management with weight loss goals, ensuring that side effects do not derail your progress. If constipation becomes intolerable, alternative GLP-1 formulations or compounded options may offer better tolerability; your provider will guide you toward the best fit for your body and lifestyle.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How long does constipation from semaglutide typically last?

Most patients experience constipation during the first two to four weeks of treatment or following a dose increase. Symptoms often improve as the body adapts, though some individuals continue to experience mild constipation throughout therapy. Aggressive hydration and fiber intake typically reduce severity within one to two weeks.

Can I take laxatives while using semaglutide from PlexusDx?

Yes, osmotic and stool-softening laxatives like MiraLAX and docusate are safe with semaglutide and do not interfere with weight loss. Avoid stimulant laxatives as daily treatments. Always notify your PlexusDx provider before starting new medications to ensure compatibility.

What foods should I eat to prevent constipation on semaglutide?

Prioritize water-rich foods such as berries, leafy greens, and cucumbers, along with high-fiber options like oats, beans, chia seeds, and whole grains. Smaller, frequent meals support both your reduced appetite and your digestive comfort, preventing the large meals that can worsen constipation despite semaglutide's slowing effect.

Is constipation a sign that semaglutide is not working for weight loss?

No. Constipation is a predictable side effect of semaglutide's mechanism—slowing stomach emptying—and does not indicate that the medication is ineffective. In fact, most patients who experience this side effect are responding well to the appetite-suppressing effects that drive weight loss.

Can the Precision Peptide Genetic Test predict constipation risk on semaglutide?

The PlexusDx Precision Peptide Genetic Test analyzes 49 peptides across 14 pathways, including GLP1R and GIPR variants that influence how your body responds to semaglutide. While the test does not directly predict constipation, variants affecting gastric motility and peptide sensitivity may inform your provider's approach to dose escalation and symptom management.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves